9
Views
15
CrossRef citations to date
0
Altmetric
Original Article

The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with Type 2 diabetes

, &
Pages 571-576 | Received 05 Mar 1996, Accepted 20 Jun 1996, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Annabelle M. Warren, Søren T. Knudsen & Mark E. Cooper. (2019) Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opinion on Therapeutic Targets 23:7, pages 579-591.
Read now

Articles from other publishers (14)

Patrícia C. Braga, Marco G. Alves, Anabela S. Rodrigues & Pedro F. Oliveira. (2022) Mitochondrial Pathophysiology on Chronic Kidney Disease. International Journal of Molecular Sciences 23:3, pages 1776.
Crossref
Ilse S. Daehn & Jeremy S. Duffield. (2021) The glomerular filtration barrier: a structural target for novel kidney therapies. Nature Reviews Drug Discovery 20:10, pages 770-788.
Crossref
David Z.I. Cherney & George L. Bakris. (2018) Novel therapies for diabetic kidney disease. Kidney International Supplements 8:1, pages 18-25.
Crossref
Maria Luiza Avancini Caramori & Peter Rossing. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric 934 957.e12 .
Ilse Daehn, Gabriella Casalena, Taoran Zhang, Shaolin Shi, Franz Fenninger, Nicholas Barasch, Liping Yu, Vivette D’Agati, Detlef Schlondorff, Wilhelm Kriz, Borje Haraldsson & Erwin P. Bottinger. (2014) Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. Journal of Clinical Investigation 124:4, pages 1608-1621.
Crossref
Alexa N Sasson. (2012) Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World Journal of Diabetes 3:1, pages 1.
Crossref
Agnès Matheson, Mark D. P. Willcox, Judith Flanagan & Bradley J. Walsh. (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes/Metabolism Research and Reviews 26:3, pages 150-171.
Crossref
Maria Luiza Avancini Caramori, Peter Rossing & Michael Mauer. 2010. Endocrinology. Endocrinology 999 1030 .
B. Terrier, L. Guillevin & L. Mouthon. (2007) Endothéline-1 et crise rénale sclérodermique. La Revue de Médecine Interne 28, pages S238-S243.
Crossref
Bieke F. Schrijvers, An S. De Vriese & Allan Flyvbjerg. (2004) From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines. Endocrine Reviews 25:6, pages 971-1010.
Crossref
Shuang-Shuang Ding, Changbin Qiu, Patrick Hess, Jian-Fei Xi, Nan Zheng & Martine Clozel. (2003) Chronic Endothelin Receptor Blockade Prevents Both Early Hyperfiltration and Late Overt Diabetic Nephropathy in the Rat. Journal of Cardiovascular Pharmacology 42:1, pages 48-54.
Crossref
M Luiza Caramori & Michael Mauer. (2003) Diabetes and nephropathy. Current Opinion in Nephrology and Hypertension 12:3, pages 273-282.
Crossref
Koh-ichi Sugimoto, Shuichi Tsuruoka & Akio Fujimura. (2002) Renal protective effect of YM598, a selective endothelin ETA receptor antagonist, against diabetic nephropathy in OLETF rats. European Journal of Pharmacology 450:2, pages 183-189.
Crossref
Gaylene M. Hargrove, Josee Dufresne, Catharine Whiteside, Daniel A. Muruve & Norman C.W. Wong. (2000) Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney International 58:4, pages 1534-1545.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.